Last updated: Jun 01, 2024
TROZON X17
is not in process of liquidation on Jun 1, 2024
Private Limited Company by guarantee without share capital use of 'Limited' exemption
United Kingdom • 15 Jun 2017 (7 years ago)
Share via
Summary
NameTROZON X17
Status
- Active
Jurisdiction
United Kingdom
United KingdomCompany number
10821171
10821171Incorporation Date15 Jun 2017 (7 years ago) / 2286 companies with the same date
Legal formPrivate Limited Company by guarantee without share capital use of 'Limited' exemption
Type of activity
- Primary:
- #7211 - Research and experimental development on biotechnology
- Secondary:
- #7219 - Other research and experimental development on natural sciences and engineering
- #8690 - Other human health activities
Contact details
Legal addressUNITED KINGDOM, KENT, WHITSTABLE, 20 GRIMTHORPE AVENUE, CT5 4QA
Officers
United Kingdom
Director
Appointed on15 Feb 2019
Country of residenceEngland
Additional data
Accounts
- First accounts made up to30 Jun 2024
due by 31 Mar 2025 - Last accounts made up to30 Jun 2023
- CategoryTOTAL EXEMPTION FULL
Confirmation statement
- Next statement date14 Jun 2024
due by 28 Jun 2024 - Last statement dated14 Jun 2023
Returns
- Next returns datedue by 13 Jul 2018
Related companies by officers
Frequently asked questions
Where is TROZON X17's headquarters?
TROZON X17's headquarters is located at UNITED KINGDOM, KENT, WHITSTABLE, 20 GRIMTHORPE AVENUE, CT5 4QA
What is TROZON X17's industry?
TROZON X17 is in the industry of Research and experimental development on biotechnology
What year was TROZON X17 started?
TROZON X17 was started in 2017
Sources: Companies House
Your trusted source for business data
Socials
English, USA
English, USA